Structure

Physi-Chem Properties

Molecular Weight:  404.22
Volume:  426.174
LogP:  5.767
LogD:  2.925
LogS:  -3.501
# Rotatable Bonds:  7
TPSA:  96.22
# H-Bond Aceptor:  6
# H-Bond Donor:  3
# Rings:  2
# Heavy Atoms:  6

MedChem Properties

QED Drug-Likeness Score:  0.253
Synthetic Accessibility Score:  4.339
Fsp3:  0.522
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  1
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.799
MDCK Permeability:  1.1817899576271884e-05
Pgp-inhibitor:  0.921
Pgp-substrate:  0.829
Human Intestinal Absorption (HIA):  0.176
20% Bioavailability (F20%):  0.949
30% Bioavailability (F30%):  0.035

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.081
Plasma Protein Binding (PPB):  88.4258804321289%
Volume Distribution (VD):  3.839
Pgp-substrate:  9.988025665283203%

ADMET: Metabolism

CYP1A2-inhibitor:  0.257
CYP1A2-substrate:  0.214
CYP2C19-inhibitor:  0.09
CYP2C19-substrate:  0.245
CYP2C9-inhibitor:  0.439
CYP2C9-substrate:  0.804
CYP2D6-inhibitor:  0.181
CYP2D6-substrate:  0.189
CYP3A4-inhibitor:  0.154
CYP3A4-substrate:  0.126

ADMET: Excretion

Clearance (CL):  6.175
Half-life (T1/2):  0.229

ADMET: Toxicity

hERG Blockers:  0.024
Human Hepatotoxicity (H-HT):  0.948
Drug-inuced Liver Injury (DILI):  0.281
AMES Toxicity:  0.102
Rat Oral Acute Toxicity:  0.795
Maximum Recommended Daily Dose:  0.033
Skin Sensitization:  0.766
Carcinogencity:  0.288
Eye Corrosion:  0.003
Eye Irritation:  0.411
Respiratory Toxicity:  0.555

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC276565

Natural Product ID:  NPC276565
Common Name*:   Harrisolanol A
IUPAC Name:   1-[(2R,3R)-3-hydroperoxy-5,7-dihydroxy-2-methyl-6-(3-methylbut-2-enyl)-2-(4-methylpent-3-enyl)-3,4-dihydrochromen-8-yl]ethanone
Synonyms:  
Standard InCHIKey:  SPYURBRWMRJZNS-WZONZLPQSA-N
Standard InCHI:  InChI=1S/C23H32O6/c1-13(2)8-7-11-23(6)18(29-27)12-17-20(25)16(10-9-14(3)4)21(26)19(15(5)24)22(17)28-23/h8-9,18,25-27H,7,10-12H2,1-6H3/t18-,23-/m1/s1
SMILES:  CC(=CCC[C@]1(C)[C@@H](Cc2c(c(CC=C(C)C)c(c(C(=O)C)c2O1)O)O)OO)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL2398519
PubChem CID:   25223416
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000002] Organoheterocyclic compounds
      • [CHEMONTID:0000123] Benzopyrans
        • [CHEMONTID:0003410] 1-benzopyrans

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO21362 Harrisonia perforata Species Rutaceae Eukaryota n.a. root n.a. PMID[16394547]
NPO21362 Harrisonia perforata Species Rutaceae Eukaryota n.a. n.a. n.a. PMID[23688954]
NPO21362 Harrisonia perforata Species Rutaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO21362 Harrisonia perforata Species Rutaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO21362 Harrisonia perforata Species Rutaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO21362 Harrisonia perforata Species Rutaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 = 31040.0 nM PMID[490728]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC276565 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.964 High Similarity NPC18886
0.9574 High Similarity NPC91902
0.9496 High Similarity NPC74397
0.9437 High Similarity NPC47388
0.9437 High Similarity NPC473133
0.9437 High Similarity NPC470670
0.931 High Similarity NPC471677
0.9301 High Similarity NPC85773
0.9291 High Similarity NPC112829
0.9241 High Similarity NPC476509
0.9241 High Similarity NPC180351
0.9236 High Similarity NPC10097
0.9231 High Similarity NPC474302
0.9225 High Similarity NPC470553
0.9225 High Similarity NPC33653
0.9225 High Similarity NPC184738
0.9225 High Similarity NPC112749
0.9225 High Similarity NPC307895
0.9203 High Similarity NPC101752
0.9178 High Similarity NPC474021
0.9178 High Similarity NPC474023
0.9178 High Similarity NPC244577
0.9178 High Similarity NPC471676
0.9178 High Similarity NPC472636
0.9178 High Similarity NPC472420
0.9178 High Similarity NPC263384
0.9178 High Similarity NPC472422
0.9172 High Similarity NPC307052
0.9172 High Similarity NPC139966
0.9172 High Similarity NPC472628
0.9167 High Similarity NPC202494
0.9161 High Similarity NPC133060
0.9161 High Similarity NPC118059
0.9161 High Similarity NPC288910
0.9161 High Similarity NPC470890
0.9161 High Similarity NPC470554
0.9155 High Similarity NPC470556
0.9155 High Similarity NPC294432
0.9149 High Similarity NPC471587
0.9149 High Similarity NPC477272
0.9143 High Similarity NPC474487
0.9143 High Similarity NPC470671
0.9143 High Similarity NPC470672
0.9143 High Similarity NPC474504
0.9143 High Similarity NPC131130
0.9122 High Similarity NPC477958
0.9116 High Similarity NPC477957
0.9116 High Similarity NPC473996
0.9116 High Similarity NPC475790
0.9116 High Similarity NPC256141
0.9116 High Similarity NPC138288
0.911 High Similarity NPC321387
0.911 High Similarity NPC105136
0.911 High Similarity NPC472421
0.911 High Similarity NPC470908
0.911 High Similarity NPC327059
0.9103 High Similarity NPC472345
0.9097 High Similarity NPC472629
0.9097 High Similarity NPC470910
0.9097 High Similarity NPC187282
0.9097 High Similarity NPC290133
0.9097 High Similarity NPC285630
0.9097 High Similarity NPC24136
0.9097 High Similarity NPC127059
0.9091 High Similarity NPC478086
0.9091 High Similarity NPC96216
0.9091 High Similarity NPC470909
0.9091 High Similarity NPC185276
0.9091 High Similarity NPC474939
0.9091 High Similarity NPC316816
0.9091 High Similarity NPC214166
0.9085 High Similarity NPC171870
0.9085 High Similarity NPC156190
0.9085 High Similarity NPC248372
0.9085 High Similarity NPC279650
0.9085 High Similarity NPC17170
0.9085 High Similarity NPC166689
0.9085 High Similarity NPC110038
0.9085 High Similarity NPC96408
0.9085 High Similarity NPC258630
0.9078 High Similarity NPC139554
0.9078 High Similarity NPC23257
0.906 High Similarity NPC215917
0.906 High Similarity NPC20530
0.906 High Similarity NPC10754
0.9054 High Similarity NPC236756
0.9054 High Similarity NPC100134
0.9054 High Similarity NPC311579
0.9054 High Similarity NPC7989
0.9054 High Similarity NPC223701
0.9054 High Similarity NPC248793
0.9054 High Similarity NPC180301
0.9054 High Similarity NPC472583
0.9054 High Similarity NPC293286
0.9054 High Similarity NPC469405
0.9054 High Similarity NPC209760
0.9048 High Similarity NPC262038
0.9048 High Similarity NPC474744
0.9048 High Similarity NPC278476
0.9048 High Similarity NPC254412
0.9048 High Similarity NPC319910
0.9048 High Similarity NPC472580
0.9048 High Similarity NPC262039
0.9048 High Similarity NPC474772
0.9048 High Similarity NPC472423
0.9048 High Similarity NPC471675
0.9034 High Similarity NPC283234
0.9034 High Similarity NPC296998
0.9034 High Similarity NPC285748
0.9034 High Similarity NPC473077
0.9034 High Similarity NPC472627
0.9028 High Similarity NPC297788
0.9028 High Similarity NPC235217
0.9028 High Similarity NPC131568
0.9028 High Similarity NPC224714
0.9028 High Similarity NPC473014
0.9028 High Similarity NPC209040
0.9028 High Similarity NPC87486
0.9028 High Similarity NPC131579
0.9028 High Similarity NPC236766
0.9028 High Similarity NPC197252
0.9028 High Similarity NPC124780
0.9021 High Similarity NPC324436
0.9021 High Similarity NPC32739
0.9021 High Similarity NPC194432
0.9021 High Similarity NPC223500
0.9021 High Similarity NPC472344
0.9021 High Similarity NPC66515
0.9021 High Similarity NPC177354
0.9021 High Similarity NPC182852
0.9021 High Similarity NPC306829
0.9021 High Similarity NPC228504
0.9021 High Similarity NPC328164
0.9021 High Similarity NPC64915
0.9021 High Similarity NPC40833
0.9021 High Similarity NPC125855
0.9021 High Similarity NPC166934
0.9021 High Similarity NPC296917
0.9021 High Similarity NPC265040
0.9021 High Similarity NPC166482
0.9021 High Similarity NPC324134
0.9021 High Similarity NPC161506
0.9021 High Similarity NPC78
0.9021 High Similarity NPC148757
0.9021 High Similarity NPC37496
0.9021 High Similarity NPC76372
0.9021 High Similarity NPC167624
0.9021 High Similarity NPC107572
0.9021 High Similarity NPC1089
0.9021 High Similarity NPC10937
0.9021 High Similarity NPC220998
0.9021 High Similarity NPC76338
0.9021 High Similarity NPC227579
0.9 High Similarity NPC156910
0.9 High Similarity NPC470398
0.9 High Similarity NPC174999
0.8993 High Similarity NPC48579
0.8993 High Similarity NPC259710
0.8993 High Similarity NPC304207
0.8993 High Similarity NPC207809
0.8993 High Similarity NPC217706
0.8993 High Similarity NPC226025
0.8986 High Similarity NPC31627
0.8986 High Similarity NPC171651
0.8986 High Similarity NPC56232
0.8986 High Similarity NPC150123
0.8986 High Similarity NPC35567
0.8986 High Similarity NPC216035
0.8986 High Similarity NPC217149
0.8986 High Similarity NPC327269
0.8986 High Similarity NPC244583
0.8986 High Similarity NPC10807
0.8986 High Similarity NPC476238
0.8986 High Similarity NPC161881
0.8986 High Similarity NPC243171
0.8986 High Similarity NPC210597
0.898 High Similarity NPC472633
0.898 High Similarity NPC38775
0.8973 High Similarity NPC160821
0.8973 High Similarity NPC132592
0.8973 High Similarity NPC145467
0.8966 High Similarity NPC246948
0.8966 High Similarity NPC267375
0.8966 High Similarity NPC176229
0.8966 High Similarity NPC20488
0.8966 High Similarity NPC67805
0.8966 High Similarity NPC142405
0.8966 High Similarity NPC316769
0.8966 High Similarity NPC111786
0.8966 High Similarity NPC301276
0.8966 High Similarity NPC214774
0.8966 High Similarity NPC83357
0.8966 High Similarity NPC82534
0.8966 High Similarity NPC475052
0.8966 High Similarity NPC54577
0.8966 High Similarity NPC312973
0.8966 High Similarity NPC88964
0.8966 High Similarity NPC470647
0.8966 High Similarity NPC195621
0.8958 High Similarity NPC150408

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC276565 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.88 High Similarity NPD2393 Clinical (unspecified phase)
0.8767 High Similarity NPD4378 Clinical (unspecified phase)
0.875 High Similarity NPD7075 Discontinued
0.8725 High Similarity NPD4380 Phase 2
0.8681 High Similarity NPD2800 Approved
0.8675 High Similarity NPD7096 Clinical (unspecified phase)
0.8671 High Similarity NPD1550 Clinical (unspecified phase)
0.8671 High Similarity NPD1552 Clinical (unspecified phase)
0.8618 High Similarity NPD8443 Clinical (unspecified phase)
0.8611 High Similarity NPD1549 Phase 2
0.8609 High Similarity NPD1934 Approved
0.8521 High Similarity NPD6651 Approved
0.8514 High Similarity NPD7410 Clinical (unspecified phase)
0.8389 Intermediate Similarity NPD2532 Approved
0.8389 Intermediate Similarity NPD2534 Approved
0.8389 Intermediate Similarity NPD2533 Approved
0.8387 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.8375 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.8345 Intermediate Similarity NPD2796 Approved
0.8312 Intermediate Similarity NPD7819 Suspended
0.8301 Intermediate Similarity NPD7411 Suspended
0.8276 Intermediate Similarity NPD1510 Phase 2
0.8252 Intermediate Similarity NPD1240 Approved
0.8247 Intermediate Similarity NPD6801 Discontinued
0.8228 Intermediate Similarity NPD6959 Discontinued
0.82 Intermediate Similarity NPD6799 Approved
0.8194 Intermediate Similarity NPD2801 Approved
0.8187 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.8187 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.8187 Intermediate Similarity NPD6166 Phase 2
0.8138 Intermediate Similarity NPD1607 Approved
0.8098 Intermediate Similarity NPD7074 Phase 3
0.8089 Intermediate Similarity NPD3882 Suspended
0.8079 Intermediate Similarity NPD1511 Approved
0.805 Intermediate Similarity NPD5494 Approved
0.8037 Intermediate Similarity NPD7054 Approved
0.8 Intermediate Similarity NPD6599 Discontinued
0.7988 Intermediate Similarity NPD7472 Approved
0.7987 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7975 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7975 Intermediate Similarity NPD7768 Phase 2
0.7974 Intermediate Similarity NPD1512 Approved
0.7963 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7911 Intermediate Similarity NPD3817 Phase 2
0.7892 Intermediate Similarity NPD7251 Discontinued
0.7892 Intermediate Similarity NPD6559 Discontinued
0.7866 Intermediate Similarity NPD3818 Discontinued
0.7862 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7844 Intermediate Similarity NPD7808 Phase 3
0.784 Intermediate Similarity NPD5711 Approved
0.784 Intermediate Similarity NPD5710 Approved
0.7831 Intermediate Similarity NPD6797 Phase 2
0.7823 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7823 Intermediate Similarity NPD5124 Phase 1
0.7815 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7815 Intermediate Similarity NPD1243 Approved
0.7806 Intermediate Similarity NPD920 Approved
0.7805 Intermediate Similarity NPD7473 Discontinued
0.7733 Intermediate Similarity NPD6099 Approved
0.7733 Intermediate Similarity NPD6100 Approved
0.7733 Intermediate Similarity NPD2935 Discontinued
0.7733 Intermediate Similarity NPD1551 Phase 2
0.773 Intermediate Similarity NPD6232 Discontinued
0.7711 Intermediate Similarity NPD7286 Phase 2
0.7711 Intermediate Similarity NPD5844 Phase 1
0.7702 Intermediate Similarity NPD3749 Approved
0.7692 Intermediate Similarity NPD5403 Approved
0.7677 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7662 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7647 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7647 Intermediate Similarity NPD4628 Phase 3
0.7647 Intermediate Similarity NPD3750 Approved
0.7647 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7633 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7619 Intermediate Similarity NPD5953 Discontinued
0.7578 Intermediate Similarity NPD5402 Approved
0.7564 Intermediate Similarity NPD5401 Approved
0.7561 Intermediate Similarity NPD1247 Approved
0.755 Intermediate Similarity NPD2799 Discontinued
0.7546 Intermediate Similarity NPD919 Approved
0.7529 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7516 Intermediate Similarity NPD2424 Discontinued
0.7515 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD2313 Discontinued
0.75 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7451 Intermediate Similarity NPD2344 Approved
0.7401 Intermediate Similarity NPD4360 Phase 2
0.7401 Intermediate Similarity NPD4363 Phase 3
0.7391 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.7386 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7365 Intermediate Similarity NPD6832 Phase 2
0.7365 Intermediate Similarity NPD4908 Phase 1
0.7361 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.7355 Intermediate Similarity NPD2654 Approved
0.7351 Intermediate Similarity NPD230 Phase 1
0.7338 Intermediate Similarity NPD2346 Discontinued
0.7337 Intermediate Similarity NPD7584 Approved
0.7321 Intermediate Similarity NPD2403 Approved
0.732 Intermediate Similarity NPD7033 Discontinued
0.732 Intermediate Similarity NPD3748 Approved
0.732 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7318 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.731 Intermediate Similarity NPD9717 Approved
0.7301 Intermediate Similarity NPD1465 Phase 2
0.7285 Intermediate Similarity NPD1613 Approved
0.7285 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7285 Intermediate Similarity NPD943 Approved
0.7279 Intermediate Similarity NPD1203 Approved
0.7278 Intermediate Similarity NPD7390 Discontinued
0.7267 Intermediate Similarity NPD3226 Approved
0.7267 Intermediate Similarity NPD6410 Clinical (unspecified phase)
0.7262 Intermediate Similarity NPD3926 Phase 2
0.7261 Intermediate Similarity NPD2309 Approved
0.7241 Intermediate Similarity NPD422 Phase 1
0.7241 Intermediate Similarity NPD1610 Phase 2
0.7237 Intermediate Similarity NPD447 Suspended
0.7198 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7184 Intermediate Similarity NPD8313 Approved
0.7184 Intermediate Similarity NPD8312 Approved
0.7181 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7168 Intermediate Similarity NPD6104 Discontinued
0.716 Intermediate Similarity NPD7458 Discontinued
0.7152 Intermediate Similarity NPD1699 Clinical (unspecified phase)
0.7151 Intermediate Similarity NPD1729 Discontinued
0.7143 Intermediate Similarity NPD4749 Approved
0.7135 Intermediate Similarity NPD3751 Discontinued
0.7134 Intermediate Similarity NPD1652 Phase 2
0.7133 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7124 Intermediate Similarity NPD6355 Discontinued
0.7115 Intermediate Similarity NPD6002 Phase 3
0.7115 Intermediate Similarity NPD6003 Clinical (unspecified phase)
0.7115 Intermediate Similarity NPD6004 Phase 3
0.7115 Intermediate Similarity NPD6005 Phase 3
0.7115 Intermediate Similarity NPD6006 Clinical (unspecified phase)
0.7101 Intermediate Similarity NPD3787 Discontinued
0.7091 Intermediate Similarity NPD8455 Phase 2
0.7086 Intermediate Similarity NPD4625 Phase 3
0.7086 Intermediate Similarity NPD3027 Phase 3
0.7083 Intermediate Similarity NPD1548 Phase 1
0.7083 Intermediate Similarity NPD9545 Approved
0.7072 Intermediate Similarity NPD4361 Phase 2
0.7072 Intermediate Similarity NPD4362 Clinical (unspecified phase)
0.7062 Intermediate Similarity NPD8434 Phase 2
0.7048 Intermediate Similarity NPD5353 Approved
0.7039 Intermediate Similarity NPD6798 Discontinued
0.7039 Intermediate Similarity NPD3268 Approved
0.7037 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7032 Intermediate Similarity NPD7097 Phase 1
0.7019 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7013 Intermediate Similarity NPD1933 Approved
0.7013 Intermediate Similarity NPD1899 Clinical (unspecified phase)
0.7011 Intermediate Similarity NPD6778 Approved
0.7011 Intermediate Similarity NPD6782 Approved
0.7011 Intermediate Similarity NPD6780 Approved
0.7011 Intermediate Similarity NPD3823 Discontinued
0.7011 Intermediate Similarity NPD6777 Approved
0.7011 Intermediate Similarity NPD6776 Approved
0.7011 Intermediate Similarity NPD6779 Approved
0.7011 Intermediate Similarity NPD6781 Approved
0.7006 Intermediate Similarity NPD2343 Clinical (unspecified phase)
0.7 Intermediate Similarity NPD7229 Phase 3
0.7 Intermediate Similarity NPD1019 Discontinued
0.7 Intermediate Similarity NPD2798 Approved
0.6989 Remote Similarity NPD7698 Approved
0.6989 Remote Similarity NPD7696 Phase 3
0.6989 Remote Similarity NPD7697 Approved
0.6989 Remote Similarity NPD7435 Discontinued
0.6988 Remote Similarity NPD5761 Phase 2
0.6988 Remote Similarity NPD5760 Phase 2
0.6987 Remote Similarity NPD4308 Phase 3
0.6987 Remote Similarity NPD651 Clinical (unspecified phase)
0.6984 Remote Similarity NPD8151 Discontinued
0.6983 Remote Similarity NPD8397 Clinical (unspecified phase)
0.6975 Remote Similarity NPD5049 Phase 3
0.6972 Remote Similarity NPD1241 Discontinued
0.6966 Remote Similarity NPD8150 Discontinued
0.6952 Remote Similarity NPD7871 Phase 2
0.6952 Remote Similarity NPD7870 Phase 2
0.6951 Remote Similarity NPD5808 Clinical (unspecified phase)
0.6944 Remote Similarity NPD9493 Approved
0.6937 Remote Similarity NPD3887 Approved
0.6936 Remote Similarity NPD7893 Clinical (unspecified phase)
0.6933 Remote Similarity NPD2797 Approved
0.6931 Remote Similarity NPD7585 Approved
0.6928 Remote Similarity NPD6844 Discontinued
0.6928 Remote Similarity NPD37 Approved
0.6928 Remote Similarity NPD1296 Phase 2
0.6928 Remote Similarity NPD411 Approved
0.6923 Remote Similarity NPD6234 Discontinued
0.6923 Remote Similarity NPD5537 Clinical (unspecified phase)
0.6919 Remote Similarity NPD7784 Clinical (unspecified phase)
0.6918 Remote Similarity NPD4196 Clinical (unspecified phase)
0.6914 Remote Similarity NPD4662 Approved
0.6914 Remote Similarity NPD4661 Approved
0.6911 Remote Similarity NPD7783 Phase 2
0.6911 Remote Similarity NPD7782 Clinical (unspecified phase)
0.691 Remote Similarity NPD8055 Clinical (unspecified phase)
0.6905 Remote Similarity NPD4967 Phase 2
0.6905 Remote Similarity NPD4965 Approved
0.6905 Remote Similarity NPD4966 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data